Steve Wong

Steve Wong joined HarbourVest in 2019 and focuses on growth equity and buyout co-investments in the Asia Pacific region. HarbourVest Partners is an independent global private markets firm whose platform spans primary funds, secondary transactions, direct co-investments, real assets and infrastructure, and private credit.

Before HarbourVest, Wong spent eight years at TPG Growth as a vice president focused on growth equity investments in China. He was also a director at Rivendell Partners in Hong Kong, where he focused on mid-market buyouts in Greater China. Earlier in his career, he held roles at McKinsey & Company, Thomson Reuters, and Arthur D. Little Management Consulting.

Wong received a BS in Chemical Engineering in 1998 and an MBA from the Kellogg School of Management in 2006, both from Northwestern University. He holds the Chartered Financial Analyst designation and speaks fluent Cantonese and Mandarin.

One current-status caveat: MarketScreener lists Wong as a private equity investor at HarbourVest Partners (Asia) Ltd.; a Hong Kong SFC public-register mirror lists “Cheuk Kwan Wong” as a representative of HarbourVest Partners (Asia) Limited from January 2019 to January 2024. I did not find a current official HarbourVest bio page for Steve Wong.

• HarbourVest’s direct co-investment strategy is to invest in operating companies alongside lead sponsors, using relationships with private equity managers to access venture, growth equity, and buyout transactions across industries and geographies.
• The firm says it sources more than 1,000 direct co-investment deals per year and invests in about 6% of sourced deals on average.
• HarbourVest states that it can invest US$10 million to US$350+ million per direct co-investment transaction.
• HarbourVest’s 2026 co-investment program targets a diversified global portfolio across buyout and growth equity strategies alongside leading private markets sponsors.
• The 2026 growth-oriented component of HarbourVest’s seventh co-investment program is intended for growth equity and expansion-stage opportunities tied to AI, healthcare innovation, and other high-growth industries and disruptive technologies.
• Asia Pacific focus areas highlighted publicly by HarbourVest include China healthcare services and consumer opportunities; supply-chain shifts benefiting India, Southeast Asia, Japan, and South Korea; and India sectors such as healthcare, pharmaceuticals, IT services, business services, consumer, and financial services.
• HarbourVest’s stated co-investment positioning emphasizes “scale, speed, and flexibility” and being “not just a source of capital” but a partner to private equity managers.